565 related articles for article (PubMed ID: 9134055)
1. Occurrence and interrelationships of complications in insulin-dependent diabetes in Finland.
Ebeling P; Koivisto VA
Acta Diabetol; 1997 Mar; 34(1):33-8. PubMed ID: 9134055
[TBL] [Abstract][Full Text] [Related]
2. Glycaemic control and microvascular complications in a large cohort of Italian Type 1 diabetic out-patients.
Lepore G; Bruttomesso D; Nosari I; Tiengo A; Trevisan R
Diabetes Nutr Metab; 2002 Aug; 15(4):232-9. PubMed ID: 12416660
[TBL] [Abstract][Full Text] [Related]
3. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.
Ohkubo Y; Kishikawa H; Araki E; Miyata T; Isami S; Motoyoshi S; Kojima Y; Furuyoshi N; Shichiri M
Diabetes Res Clin Pract; 1995 May; 28(2):103-17. PubMed ID: 7587918
[TBL] [Abstract][Full Text] [Related]
4. Pattern of long-term complications in Sudanese insulin-treated diabetic patients.
Elbagir MN; Eltom MA; Mahadi EO; Berne C
Diabetes Res Clin Pract; 1995 Oct; 30(1):59-67. PubMed ID: 8745207
[TBL] [Abstract][Full Text] [Related]
5. The association between retinopathy, nephropathy, cardiovascular disease and long-term metabolic control in type 1 diabetes mellitus: a 5 year follow-up study of 442 adult patients in routine care.
Agardh CD; Agardh E; Torffvit O
Diabetes Res Clin Pract; 1997 Mar; 35(2-3):113-21. PubMed ID: 9179466
[TBL] [Abstract][Full Text] [Related]
6. The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial.
Diabetes; 1996 Oct; 45(10):1289-98. PubMed ID: 8826962
[TBL] [Abstract][Full Text] [Related]
7. Increased prevalence of proliferative retinopathy and cardiovascular autonomic dysfunction in IDDM patients with proteinuria.
Zander E; Seidlein I; Herfurth S; Heinke P; Chlup R; Badendick K; Strese J; Zander G; Schulz B
Exp Clin Endocrinol; 1992; 99(2):102-7. PubMed ID: 1639116
[TBL] [Abstract][Full Text] [Related]
8. High prevalence of diabetic retinopathy and nephropathy in Polynesians of Western Samoa.
Collins VR; Dowse GK; Plehwe WE; Imo TT; Toelupe PM; Taylor HR; Zimmet PZ
Diabetes Care; 1995 Aug; 18(8):1140-9. PubMed ID: 7587849
[TBL] [Abstract][Full Text] [Related]
9. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial.
Diabetes; 1995 Aug; 44(8):968-83. PubMed ID: 7622004
[TBL] [Abstract][Full Text] [Related]
10. Predictors of abnormal cardiovascular autonomic function measured by frequence domain analysis of heart rate variability and conventional tests in patients with type 1 diabetes.
Mäkimattila S; Schlenzka A; Mäntysaari M; Bergholm R; Summanen P; Saar P; Erkkilä H; Yki-Järvinen H
Diabetes Care; 2000 Nov; 23(11):1686-93. PubMed ID: 11092293
[TBL] [Abstract][Full Text] [Related]
11. Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
Cardoso CRL; Leite NC; Moram CBM; Salles GF
Cardiovasc Diabetol; 2018 Feb; 17(1):33. PubMed ID: 29477146
[TBL] [Abstract][Full Text] [Related]
12. Occurrence of late specific complications in type II (non-insulin-dependent) diabetes mellitus.
Wirta OR; Pasternack AI; Oksa HH; Mustonen JT; Koivula TA; Helin HJ; Lähde YE
J Diabetes Complications; 1995; 9(3):177-85. PubMed ID: 7548982
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with diabetic microangiopathy: a study of 157 type I (insulin-dependent) diabetic patients.
Billault BM; Passa PL
J Diabet Complications; 1991; 5(4):238-43. PubMed ID: 1779019
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for microvascular complications of diabetes among South Indian subjects with type 2 diabetes--the Chennai Urban Rural Epidemiology Study (CURES) Eye Study-5.
Pradeepa R; Anjana RM; Unnikrishnan R; Ganesan A; Mohan V; Rema M
Diabetes Technol Ther; 2010 Oct; 12(10):755-61. PubMed ID: 20818974
[TBL] [Abstract][Full Text] [Related]
15. Lipid and blood pressure treatment goals for type 1 diabetes: 10-year incidence data from the Pittsburgh Epidemiology of Diabetes Complications Study.
Orchard TJ; Forrest KY; Kuller LH; Becker DJ;
Diabetes Care; 2001 Jun; 24(6):1053-9. PubMed ID: 11375370
[TBL] [Abstract][Full Text] [Related]
16. Reversed circadian blood pressure rhythm is associated with occurrences of both fatal and nonfatal vascular events in NIDDM subjects.
Nakano S; Fukuda M; Hotta F; Ito T; Ishii T; Kitazawa M; Nishizawa M; Kigoshi T; Uchida K
Diabetes; 1998 Sep; 47(9):1501-6. PubMed ID: 9726241
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for the development of micro-vascular complications of type 2 diabetes in a single-centre cohort of patients.
Teliti M; Cogni G; Sacchi L; Dagliati A; Marini S; Tibollo V; De Cata P; Bellazzi R; Chiovato L
Diab Vasc Dis Res; 2018 Sep; 15(5):424-432. PubMed ID: 29911415
[TBL] [Abstract][Full Text] [Related]
18. The prevalence and severity of microvascular complications in pancreatic diabetes and IDDM.
Levitt NS; Adams G; Salmon J; Marks IN; Musson G; Swanepoel C; Levy M; Byrne MJ
Diabetes Care; 1995 Jul; 18(7):971-4. PubMed ID: 7555558
[TBL] [Abstract][Full Text] [Related]
19. Adult stature and diabetes complications in patients with type 1 diabetes: the FinnDiane Study and the diabetes control and complications trial.
Wadén J; Forsblom C; Thorn LM; Saraheimo M; Rosengård-Bärlund M; Heikkilä O; Hietala K; Ong K; Wareham N; Groop PH;
Diabetes; 2009 Aug; 58(8):1914-20. PubMed ID: 19491208
[TBL] [Abstract][Full Text] [Related]
20. Incidence of microvascular complications in type 1 diabetic subjects with limited joint mobility: a 10-year prospective study.
McCance DR; Crowe G; Quinn MJ; Smye M; Kennedy L
Diabet Med; 1993 Nov; 10(9):807-10. PubMed ID: 8281723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
